Rosanna Parlato, Hans Cruz,
Christiane Otto,
Patricia Murtra,
Jan Rodriguez Parkitna,
Miquel Martin,
Simona A. Bura,
Yvonne Begus-Nahrmann,
Oliver Von Bohlen und Halbach,
Rafael Maldonado,
Günther Schütz,
Christian Lüscher
[show abstract]
[hide abstract]
ABSTRACT: J. Neurochem. (2010) 115, 563–573.AbstractRepeated exposure to opiates leads to cellular and molecular changes and behavioral alterations reflecting a state of dependence. In noradrenergic neurons, cyclic AMP (cAMP)-dependent pathways are activated during opiate withdrawal, but their contribution to the activity of locus coeruleus noradrenergic neurons and behavioral manifestations remains controversial. Here, we test whether the cAMP-dependent transcription factors cAMP responsive element binding protein (CREB) and cAMP-responsive element modulator (CREM) in noradrenergic neurons control the cellular markers and the physical signs of morphine withdrawal in mice. Using the Cre/loxP system we ablated the Creb1 gene in noradrenergic neurons. To avoid adaptive effects because of compensatory up-regulation of CREM, we crossed the conditional Creb1 mutant mice with a Crem−/− line. We found that the enhanced expression of tyrosine hydroxylase normally observed during withdrawal was attenuated in CREB/CREM mutants. Moreover, the withdrawal-associated cellular hyperactivity and c-fos expression was blunted. In contrast, naloxone-precipitated withdrawal signs, such as jumping, paw tremor, tremor and mastication were preserved. We conclude by a specific genetic approach that the withdrawal-associated hyperexcitability of noradrenergic neurons depends on CREB/CREM activity in these neurons, but does not mediate several behavioral signs of morphine withdrawal.
Journal of Neurochemistry 08/2010; 115(3):563 - 573. · 4.06 Impact Factor
